- Home
- HTGC vs CPRX Comparison
HTGC vs CPRX Comparison
Compare HTGC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTGC
- CPRX
- Stock Information
- Founded
- HTGC 2003
- CPRX 2002
- Country
- HTGC United States
- CPRX United States
- Employees
- HTGC N/A
- CPRX N/A
- Industry
- HTGC Investment Managers
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- HTGC Finance
- CPRX Health Care
- Exchange
- HTGC Nasdaq
- CPRX Nasdaq
- Market Cap
- HTGC 3.2B
- CPRX 2.9B
- IPO Year
- HTGC 2005
- CPRX 2006
- Fundamental
- Price
- HTGC $18.74
- CPRX $21.46
- Analyst Decision
- HTGC Buy
- CPRX Strong Buy
- Analyst Count
- HTGC 8
- CPRX 6
- Target Price
- HTGC $20.81
- CPRX $32.83
- AVG Volume (30 Days)
- HTGC 948.3K
- CPRX 1.4M
- Earning Date
- HTGC 07-31-2025
- CPRX 08-06-2025
- Dividend Yield
- HTGC 10.10%
- CPRX N/A
- EPS Growth
- HTGC N/A
- CPRX 178.13
- EPS
- HTGC 1.33
- CPRX 1.57
- Revenue
- HTGC $491,549,000.00
- CPRX $534,645,999.00
- Revenue This Year
- HTGC $5.22
- CPRX $16.37
- Revenue Next Year
- HTGC $9.85
- CPRX $8.80
- P/E Ratio
- HTGC $13.97
- CPRX $13.68
- Revenue Growth
- HTGC 3.02
- CPRX 29.97
- 52 Week Low
- HTGC $15.65
- CPRX $14.97
- 52 Week High
- HTGC $22.04
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- HTGC 66.04
- CPRX 32.68
- Support Level
- HTGC $17.88
- CPRX $20.95
- Resistance Level
- HTGC $18.10
- CPRX $22.07
- Average True Range (ATR)
- HTGC 0.25
- CPRX 0.63
- MACD
- HTGC 0.06
- CPRX -0.20
- Stochastic Oscillator
- HTGC 91.07
- CPRX 17.23
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).